AROC vs CVX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AROC's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. Despite strong profitability metrics and robust earnings growth, elevated debt levels and weak technical momentum weigh on overall health. The stock trades above the Graham Number of $16.59 but below the growth-based intrinsic value of $44.55, suggesting a fair valuation given growth expectations. Analysts are bullish with a $31.56 target, though insider selling and a low technical trend score introduce caution.
CVX shows bearish fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
AROC vs CVX: Head-to-Head Comparison
This page compares Archrock, Inc. (AROC) and Chevron Corporation (CVX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.